Virologic failure
Showing 1 - 25 of >10,000
HIV, AIDS, Virologic Failure Trial (Maintenance on TLD treatment strategy, Individualized Care treatment strategy, Immediate
Not yet recruiting
- HIV Infections
- +2 more
- Maintenance on TLD treatment strategy
- +2 more
- (no location specified)
May 9, 2022
Virologic Failure and Drug Resistance at and After Switching to
Active, not recruiting
- Hiv
- +2 more
-
Lilongwe, Malawi
- +1 more
Feb 14, 2022
HIV, AIDS Trial in Durban, Mbarara (HIV-1 RNA Resistance Testing)
Completed
- HIV
- AIDS
- HIV-1 RNA Resistance Testing
-
Durban, South Africa
- +1 more
Mar 28, 2022
HIV Trial in United States (Abacavir sulfate, Emtricitabine, Lamivudine)
Completed
- HIV Infections
- Abacavir sulfate
- +6 more
-
Chicago, Illinois
- +3 more
Oct 28, 2021
COVID-19 Trial in Hà N?i (KOVIR (TD0068) oral softgel, Placebo oral softgel)
Recruiting
- COVID-19
- KOVIR (TD0068) oral softgel
- Placebo oral softgel
-
Hà Nội, VietnamNational hospital for tropical diseases
Jan 25, 2022
Viral Resistance, Treatment Failure Trial in Eldoret (Electronic Dose Monitoring (MEMS))
Completed
- Viral Resistance
- Treatment Failure
- Electronic Dose Monitoring (MEMS)
-
Eldoret, KenyaMoi Teaching and Referral Hospital - AMPATH Center
Jul 20, 2020
HIV Trial in Puerto Rico, United States (Indinavir sulfate, Abacavir sulfate, Nelfinavir mesylate)
Completed
- HIV Infections
- Indinavir sulfate
- +9 more
-
Birmingham, Alabama
- +52 more
Oct 27, 2021
HIV, Viremia, Pregnancy Related Trial in Kisumu, Nyakach, Nyando (Enhanced virologic monitoring)
Not yet recruiting
- HIV Infections
- +2 more
- Enhanced virologic monitoring
-
Kisumu, Kenya
- +3 more
Apr 25, 2023
HIV-1-infection Trial in San Francisco (PRO 140 350, PRO 140 525, PRO 140 700)
Active, not recruiting
- HIV-1-infection
- PRO 140 350
- +2 more
-
San Francisco, CaliforniaQuest Clinical Research
Mar 4, 2022
HIV, Human Immunodeficiency Virus Trial in San Francisco (PRO 140 350mg weekly SQ injection.)
Active, not recruiting
- HIV
- Human Immunodeficiency Virus
- PRO 140 350mg weekly SQ injection.
-
San Francisco, CaliforniaCD01-Extension Investigational Site
Sep 28, 2021
HIV Trial in United States (PRO 140 (350 mg), PRO 140 (525 mg), PRO 140 (700 mg))
Active, not recruiting
- HIV
- PRO 140 (350 mg)
- +2 more
-
La Mesa, California
- +11 more
Jan 13, 2022
Contributing Factors for Poor HIV Treatment Response in TB/HIV
Recruiting
- Tuberculosis
- +2 more
- Observational study
-
Kumasi, GhanaKwame Nkrumah University of Science and Technology
Mar 23, 2022
HIV, Human Immunodeficiency Virus Trial in San Francisco (PRO 140 350mg weekly SQ injection.)
Completed
- HIV
- Human Immunodeficiency Virus
- PRO 140 350mg weekly SQ injection.
-
San Francisco, CaliforniaQuest Clinical Research
Sep 28, 2021
HIV, Substance Use Disorders Trial in United States (Connections App)
Not yet recruiting
- HIV Infections
- Substance Use Disorders
- Connections App
-
Denver, Colorado
- +7 more
Oct 25, 2023
Dolutegravir Implementation in Sub-Saharan Africa
Recruiting
- HIV-1-infection
- This is an observational study only.
-
Somkele, KwaZulu-Natal, South Africa
- +1 more
Feb 15, 2022
HIV Trial in Spain (Dolutegravir 50 MG / Lamivudine 300 MG Oral Tablet [Dovato])
Active, not recruiting
- HIV Infections
- Dolutegravir 50 MG / Lamivudine 300 MG Oral Tablet [Dovato]
-
Vigo, Pontevedra, Spain
- +16 more
Jun 20, 2022
Doravirine Based Regimens in Clinical Practice in Europe
Not yet recruiting
- HIV I Infection
- (no location specified)
Aug 2, 2022
Chronic Hepatitis C Virus, Hepatitis C, Chronic, Hepatitis C Trial in Bucuresti (Bemnifosbuvir, Ruzasvir)
Recruiting
- Chronic Hepatitis C Virus
- +4 more
-
Bucuresti, BUC, RomaniaAtea Study Site
Jun 15, 2023
Maviret in Adolescent Chronic Hepatitis C Virus
Recruiting
- Hepatitis C Virus (HCV)
-
Kariya-shi, Aichi, Japan
- +34 more
Oct 27, 2022
Hepatitis C Infection, HIV Infection Trial in Brazil, Puerto Rico, United States (Glecaprevir/Pibrentasvir (G/P), Ribavirin
Recruiting
- Hepatitis C Infection
- HIV Infection
- Glecaprevir/Pibrentasvir (G/P)
- Ribavirin (RBV)
-
San Diego, California
- +15 more
Dec 19, 2022
Human Immunodeficiency Virus Type 1 (HIV-1) Trial in Worldwide (Cabotegravir Injectable Suspension, Rilpivirine Injectable
Completed
- Human Immunodeficiency Virus Type 1 (HIV-1)
- Cabotegravir Injectable Suspension
- Rilpivirine Injectable Suspension
-
Bakersfield, California
- +31 more
May 31, 2023
HIV-1-infection Trial (Cabotegravir/Rilpivirine, Antiretroviral)
Recruiting
- HIV-1-infection
-
Kisumu, Kenya
- +6 more
Feb 1, 2023